Expression and immunogenicity of oncofetal antigen-immature laminin receptor in human renal cell carcinoma.

[1]  G. Bartsch,et al.  Mature Dendritic Cells Induce T-Helper Type-1-Dominant Immune Responses in Patients with Metastatic Renal Cell Carcinoma , 2000, Urologia Internationalis.

[2]  J W Rohrer,et al.  37 kiloDalton oncofetal antigen protein and immature laminin receptor protein are identical, universal T-cell inducing immunogens on primary rodent and human cancers. , 1999, Anticancer research.

[3]  J. Miller,et al.  CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[4]  A. Barsoum,et al.  Human breast carcinoma patients develop clonable oncofetal antigen-specific effector and regulatory T lymphocytes. , 1999, Journal of immunology.

[5]  H. Klocker,et al.  Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells. , 1999, The Journal of urology.

[6]  S. Weiss,et al.  Role of the 37 kDa laminin receptor precursor in the life cycle of prions. , 1999, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

[7]  G. Bartsch,et al.  CD83+ blood dendritic cells as a vaccine for immunotherapy of metastatic renal-cell cancer , 1998, The Lancet.

[8]  A. Barsoum,et al.  Tumors express both unique TSTA and crossprotective 44 kDa oncofetal antigen. , 1998, Immunology today.

[9]  C. Kurts,et al.  Brief Definitive Report Major Histocompatibility Complex Class I–restricted Cross-presentation Is Biased towards High Dose Antigens and Those Released during Cellular Destruction , 2022 .

[10]  R. Steinman,et al.  Dendritic Cells as Adjuvants for Immune-mediated Resistance to Tumors , 1997, The Journal of experimental medicine.

[11]  F. Edenhofer,et al.  The human 37-kDa laminin receptor precursor interacts with the prion protein in eukaryotic cells , 1997, Nature Medicine.

[12]  H. Klocker,et al.  Human renal‐cell carcinoma tissue contains dendritic cells , 1996, International journal of cancer.

[13]  R. Motzer,et al.  Renal-cell carcinoma. , 1996, The New England journal of medicine.

[14]  J. Coggin,et al.  CD8 T cell clones inhibit antitumor T cell function by secreting IL-10. , 1995, Journal of immunology.

[15]  E. Halapi,et al.  Lack of interleukin‐2 (IL‐2) expression and selective expression of IL‐10 mRNA in human renal cell carcinoma , 1995, International journal of cancer.

[16]  L. Chen,et al.  In vitro priming of tumor-reactive cytolytic T lymphocytes by combining IL-10 with B7-CD28 costimulation. , 1995, Journal of immunology.

[17]  E. Dratz,et al.  Studies of the structure of the metastasis-associated 67 kDa laminin binding protein: fatty acid acylation and evidence supporting dimerization of the 32 kDa gene product to form the mature protein. , 1995, Biochemistry.

[18]  A. Barsoum,et al.  Characterization of RFM mouse T lymphocyte anti-oncofetal antigen immunity in apparent tumor-free, long-term survivors of sublethal X-irradiation by limiting dilution T lymphocyte cloning. , 1995, Journal of immunology.

[19]  G. Brawerman,et al.  A 33-kDa polypeptide with homology to the laminin receptor: component of translation machinery. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[20]  A. Barsoum,et al.  Expression of 44-kilodalton oncofetal antigen as a premalignancy marker in X irradiation-induced murine T-cell lymphoma. , 1992, Journal of the National Cancer Institute.

[21]  A. Zlotnik,et al.  IL-10: a novel cytotoxic T cell differentiation factor. , 1991, Journal of immunology.

[22]  Coggin Jh.  Cross-reacting tumor associated transplantation antigen on primary 3-methylcholanthrene-induced BALB/c sarcomas. , 1989 .

[23]  W. Payne,et al.  Mouse monoclonal antibody to embryonic antigen: development, cross-reactivity with rodent and human tumors, and preliminary polypeptide characterization. , 1985, Journal of the National Cancer Institute.